(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

RESTIX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: US

Quick snapshot

RESTIX

ST13

US500000090704309

Class

5

Filing

90704309

Registration

6723934

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

22

Latest update

05/06/2026

Classification

Registered

Trademark type

Combined

Nice classes

5

Filing date

05/11/2021

Registration date

05/24/2022

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/24/2022

Last transaction

05/06/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

Drawing code

3

Owner type

99

Owner location

(Barcelona), ES

Examiner

CAHILL, CLARE GALLAGHER

Law office

L40

Current location

TMEG LAW OFFICE 104

Mark description

The mark consists of the wording "RESTIX" appearing in a blue stylized font with a blue droplet design element.

Holders and representatives

Holders

LABORATORIOS SALVAT, S.A.

Representatives

Maria A. Scungio Cowan, Liebowitz & Latman, P.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for treatment of diseases related to the ear; ophthalmic preparations; ear drops; eye drops; is expressly excluded any product directly used on the skin

Publications

History of USPTO decisions and trademark events.

22 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/04/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/04/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/04/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/24/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

05/24/2022

DP1B

1(B) BASIS DELETED; PROCEED TO REGISTRATION

04/04/2022

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

04/04/2022

IUCN

NOTICE OF ALLOWANCE CANCELLED

03/02/2022

D1BR

TEAS DELETE 1(B) BASIS RECEIVED

03/02/2022

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

03/01/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/04/2022

PUBO

PUBLISHED FOR OPPOSITION

01/04/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/15/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/01/2021

XAEC

EXAMINER'S AMENDMENT ENTERED

12/01/2021

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

12/01/2021

GNEA

EXAMINERS AMENDMENT E-MAILED

12/01/2021

CNEA

EXAMINERS AMENDMENT -WRITTEN

12/01/2021

DOCK

ASSIGNED TO EXAMINER

11/29/2021

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

08/12/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/11/2021

NWAP

NEW APPLICATION ENTERED

05/14/2021

Continuous trademark protection

Get notified about every new filing that threatens RESTIX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.